Plasma levels of TF antigen, TF activity, TF-containing microparticles and FVIIa are elevated in patients with type 1 and type 2 diabetes when compared with control individuals [10–15] and glucose-lowering drugs such as metformin and exenatide downregulate TF expression [20, 21]. This evidence concerns the gene TF and type 2 diabetes mellitus.